➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKinsey
McKesson
Boehringer Ingelheim
Colorcon

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Erythromycin - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for erythromycin and what is the scope of freedom to operate?

Erythromycin is the generic ingredient in fifty-two branded drugs marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, Arbor Pharms Llc, Barr, Mylan, Altana, Fougera Pharms, Padagis Us, Teligent, Syosset, Akorn, Bausch And Lomb, Pharmaderm, Pharmafair, Dista, Bausch, Paddock Llc, Taro, Arbor Pharms Inc, Merz Pharms, Saptalis Pharms, Alpharma Us Pharms, Lilly, Renaissance Pharma, Wockhardt Bio Ag, Dow Pharm, Westwood Squibb, Ivax Sub Teva Pharms, Johnson And Johnson, Amneal Pharms Co, Torrent, Solvay, Robins Ah, Orange, Teva Pharms Usa Inc, Watson Labs, Cosette, Life Labs, Amneal Pharms, Ani Pharms, Par Pharm Inc, Ross Labs, Pharmacia And Upjohn, Naska, Wyeth Ayerst, Alra, Abbott, Elkins Sinn, Abraxis Pharm, Baxter Hlthcare, Exela Pharma, Teva Parenteral, Bristol, Warner Chilcott, Lederle, Purepac Pharm, Bristol Myers Squibb, and Pfizer, and is included in one hundred and thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are one hundred and three drug master file entries for erythromycin. Twenty-eight suppliers are listed for this compound.

Drug Prices for erythromycin

See drug prices for erythromycin

Drug Sales Revenue Trends for erythromycin

See drug sales revenues for erythromycin

Recent Clinical Trials for erythromycin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mahidol UniversityN/A
Cairo UniversityEarly Phase 1
Myovant Sciences GmbHPhase 1

See all erythromycin clinical trials

Pharmacology for erythromycin
Medical Subject Heading (MeSH) Categories for erythromycin

US Patents and Regulatory Information for erythromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dista ILOSONE erythromycin estolate TABLET, CHEWABLE;ORAL 061895-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Robins Ah ROBIMYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061633-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Parke Davis ERYTHROMYCIN ETHYLSUCCINATE erythromycin ethylsuccinate SUSPENSION;ORAL 062231-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Cosette ERYTHROMYCIN ESTOLATE erythromycin estolate SUSPENSION;ORAL 062169-002 Oct 17, 1990 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Solvay R-P MYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061659-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Akorn ERYTHROMYCIN erythromycin OINTMENT;OPHTHALMIC 064030-001 Jul 18, 1996 AT RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pharmafair ERYTHROMYCIN erythromycin SOLUTION;TOPICAL 062485-001 Jul 11, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
McKinsey
McKesson
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.